These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2618992)

  • 1. [The central nervous system arousing effects of ketamine are decreased by addition of midazolam. A post-anesthesia study of patients following maxillary surgery with spontaneous respiration].
    Freye E; Dähn H; Engel M
    Anasth Intensivther Notfallmed; 1989 Dec; 24(6):368-72. PubMed ID: 2618992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Ketamine-midazolam combination for anesthesia of rabbits--results of neuroelectrophysiologic studies using evoked potentials].
    Troitzsch D; Peukert A; Vogt S
    Berl Munch Tierarztl Wochenschr; 1995 Apr; 108(4):143-7. PubMed ID: 7575383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. S(+)-ketamine attenuates increase in electroencephalograph activity and amplitude height of sensory-evoked potentials during rapid opioid detoxification.
    Freye E; Latasch L; Levy JV
    Anesth Analg; 2006 May; 102(5):1439-44. PubMed ID: 16632823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacodynamic effects of S-(+)-ketamine on EEG, evoked potentials and respiration. A study in the awake dog].
    Freye E; Latasch L; Schmidhammer H
    Anaesthesist; 1992 Sep; 41(9):527-33. PubMed ID: 1416007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Topographic electroencephalometry following anesthesia induction with ketamine-midazolam].
    Zickmann B; Boldt J; Schindler E; Wulf K; Dapper F; Hempelmann G
    Anaesthesist; 1994 Nov; 43 Suppl 2():S59-67. PubMed ID: 7840416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increase in delta- and beta-wave activity of the EEG during rapid opiate detoxification (ROD)-reversal by administration of the non-specific NMDA-antagonist S+ ketamine-.
    Freye E; Partecke LB; Levy JV
    Neurophysiol Clin; 2005 Feb; 35(1):25-32. PubMed ID: 15808965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Interaction of S-(+)-ketamine with opiate receptors. Effects on EEG, evoked potentials and respiration in awake dogs].
    Freye E; Latasch L; Schmidhammer H; Portoghese P
    Anaesthesist; 1994 Nov; 43 Suppl 2():S52-8. PubMed ID: 7840415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [EEG power spectra and evoked potentials during alfentanil/midazolam analgesia-sedation in intensive care patients].
    Freye E; Neruda B; Falke K
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1991 Nov; 26(7):384-8. PubMed ID: 1772937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Slow EEG-power spectra correlate with haemodynamic changes during laryngoscopy and intubation following induction with fentanyl or sufentanil.
    Freye E; Dehnen-Seipel H; Latasch L; Behler M; Wilder-Smith OH
    Acta Anaesthesiol Belg; 1999; 50(2):71-6. PubMed ID: 10418645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of ageing on the EEG during pentobarbital and ketamine anaesthesia.
    Fu Y; Guo L; Zhang J; Chen Y; Wang X; Zeng T; Tian S; Ma Y
    Eur J Anaesthesiol; 2008 Oct; 25(10):826-33. PubMed ID: 18570701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anesthetic technique (sufentanil versus ketamine plus midazolam) and quantitative electroencephalographic changes after cardiac surgery.
    Smith FJ; Bartel PR; Hugo JM; Becker PJ
    J Cardiothorac Vasc Anesth; 2006 Aug; 20(4):520-5. PubMed ID: 16884982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Postoperative reversal of loss of vigilance following midazolam with the use of the antagonist flumazenil (Ro 15-1788). A comparative study with a placebo and the use of EEG-power spectra].
    Freye E; Fournell A
    Anaesthesist; 1988 Mar; 37(3):162-6. PubMed ID: 3132866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ketamine and evoked potentials].
    Kochs E; Bischoff P
    Anaesthesist; 1994 Nov; 43 Suppl 2():S8-14. PubMed ID: 7840419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Acoustic and somatosensory evoked cortical potentials in sedation with midazolam and drug antagonism with flumazenil].
    Kochs E; Wüst P; Blanc I; Schulte am Esch J
    Anasth Intensivther Notfallmed; 1989 Feb; 24(1):49-56. PubMed ID: 2496619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of ketamine on somatosensory evoked potentials during nitrous oxide anesthesia in humans].
    Nishiyama Y
    Masui; 1990 Aug; 39(8):984-7. PubMed ID: 2232141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioid receptors-mediated respiratory effects and antinociception after S(+)-ketamine.
    Latasch L; Freye E
    Acta Anaesthesiol Belg; 1993; 44(3):93-102. PubMed ID: 8310788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the effects of propofol and midazolam on the cardiovascular autonomic nervous system during combined spinal and epidural anesthesia.
    Hidaka S; Kawamoto M; Kurita S; Yuge O
    J Clin Anesth; 2005 Feb; 17(1):36-43. PubMed ID: 15721728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatosensory evoked potentials by median nerve stimulation in children during thiopental/sevoflurane anesthesia and the additive effects of ketoprofen and fentanyl.
    Westerén-Punnonen S; Yppärilä-Wolters H; Partanen J; Nieminen K; Hyvärinen A; Kokki H
    Anesth Analg; 2008 Sep; 107(3):799-805. PubMed ID: 18713887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The opioid tramadol demonstrates excitatory properties of non-opioid character--a preclinical study using alfentanil as a comparison].
    Freye E; Latasch L; Von Bredow G; Neruda B
    Schmerz; 1998 Feb; 12(1):19-24. PubMed ID: 12799988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute central effects of the calcium channel blocker and antiglutamatergic drug caroverine. Double-blind, placebo-controlled, EEG mapping and psychometric studies after intravenous and oral administration.
    Saletu B; Grünberger J; Anderer P; Linzmayer L; König P
    Arzneimittelforschung; 1995 Mar; 45(3):217-29. PubMed ID: 7741773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.